Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and Efficacy.

Saved in:
Bibliographic Details
Title: Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and Efficacy.
Authors: Stawerska R, Choe J, Wang R, Wajnrajch MP, Cara JF, Thomas M, La Torre D, Taylor CT, Phillip M, Steelman J, Deal CL, Silverman LA
Source: Hormone research in paediatrics [Horm Res Paediatr] 2026 Jun 01, pp. 1-19. Date of Electronic Publication: 2026 Jun 01.
Publication Type: Journal Article
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 101525157 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1663-2826 (Electronic) Linking ISSN: 16632818 NLM ISO Abbreviation: Horm Res Paediatr Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1663-2826
DOI:10.1159/000552183